KR950005310A - 근시치료제의 제조방법 - Google Patents

근시치료제의 제조방법 Download PDF

Info

Publication number
KR950005310A
KR950005310A KR1019930015513A KR930015513A KR950005310A KR 950005310 A KR950005310 A KR 950005310A KR 1019930015513 A KR1019930015513 A KR 1019930015513A KR 930015513 A KR930015513 A KR 930015513A KR 950005310 A KR950005310 A KR 950005310A
Authority
KR
South Korea
Prior art keywords
myopia
preparation
apomorphine
treatment
room temperature
Prior art date
Application number
KR1019930015513A
Other languages
English (en)
Other versions
KR960011239B1 (ko
Inventor
민병무
Original Assignee
민병무
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 민병무 filed Critical 민병무
Priority to KR1019930015513A priority Critical patent/KR960011239B1/ko
Publication of KR950005310A publication Critical patent/KR950005310A/ko
Application granted granted Critical
Publication of KR960011239B1 publication Critical patent/KR960011239B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Abstract

본 발명은 근시 치료 및 근시 진행을 예방하기 위한 근시치료제의 제조방법에 관한 것으로, 본 발명의 제조공정은 1. 아포모르핀(apomorphine HCL)안약 제조공정 아포모르핀 1gm(1%), 글리세린 2gm(2%), 증류수 97gm(97%)를 혼합하여 10분간 상온에서 흔든후 PH7.4가 되게 제조하고, 2. 브로모크립틴(bromocriptine)안약 제조공정 브로모크립틴 원액 0.025GM(0.025%) 폴리비닐 알콜(polyvinyl-alcohol) 1gm(1%), 증류수 98.875gm(98.875%)을 혼합하여 10분간 상온에서 흔든후 PH7.4가 되게 제조하는 것이며, 이러한 본 발명은 도파민 수용기 자극제인 아포모르핀과 브로모크립틴을 주원료로한 근시치료제를 제조하는 것을 특징으로 하고 있는 것으로서, 본 발명의 치료제를 근시안구에 점안할 경우 안축장의 성장을 억제시켜 근시 치료를 쉽게 할수가 있으므로 종래 근시치료를 위해 안경을 착용하거나 각막 수술을 할 필요가 없이 간편한 방법으로 근시를 완치할 수 있는 매우 획기적인 발명인 것이다.

Description

근시치료제의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 아포모르핀(apomorphine HCL) 1gm(1%), 글리세린 2gm(2%), 증류수 97gm(97%)를 혼합하여 상온에서 흔든후 PH7.4의 아포모르핀 안약을 제조함을 특징으로 하는 근시치료제의 제조방법.
  2. 브로모크립틴(bromocriptine) 원액 0.025gm(0.025%) 폴리비닐 알콜(polyvinyl-alcohol) 1gm(1%), 증류수 98.875gm(98.875%)을 혼합하여 상온에서 10분간 흔든후 PH7.4의 브로모크립틴 안약을 제조함을 특징으로 하는 근시치료제의 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019930015513A 1993-08-09 1993-08-09 근시 치료제의 제조방법 KR960011239B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019930015513A KR960011239B1 (ko) 1993-08-09 1993-08-09 근시 치료제의 제조방법

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019930015513A KR960011239B1 (ko) 1993-08-09 1993-08-09 근시 치료제의 제조방법

Publications (2)

Publication Number Publication Date
KR950005310A true KR950005310A (ko) 1995-03-20
KR960011239B1 KR960011239B1 (ko) 1996-08-21

Family

ID=19361070

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930015513A KR960011239B1 (ko) 1993-08-09 1993-08-09 근시 치료제의 제조방법

Country Status (1)

Country Link
KR (1) KR960011239B1 (ko)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100532655B1 (ko) * 1996-12-19 2006-02-28 신에쓰 가가꾸 고교 가부시끼가이샤 에폭시수지조성물및반도체장치
KR20190057871A (ko) 2017-11-21 2019-05-29 고려대학교 산학협력단 가상현실을 이용한 근시 억제 장치

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100532655B1 (ko) * 1996-12-19 2006-02-28 신에쓰 가가꾸 고교 가부시끼가이샤 에폭시수지조성물및반도체장치
KR20190057871A (ko) 2017-11-21 2019-05-29 고려대학교 산학협력단 가상현실을 이용한 근시 억제 장치

Also Published As

Publication number Publication date
KR960011239B1 (ko) 1996-08-21

Similar Documents

Publication Publication Date Title
DE69634414D1 (de) Verwendung von substituierten isochinolinsulfonyl-verbindungen zur herstellung eines medikaments für die behandlung von glaukom und okularer ischämie
ATE186221T1 (de) Herstellung von mikropartikeln
DE69525761T2 (de) MITTEL MIT GESTEUERTER FREISETZUNG, DIE EINE UMGEKEHRTE MICELLARE (L2) STRUKTUR ODER EINE NORMALE MICELLARE (l1) STRUKTUR BILDEN
ATE202706T1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
KR910004187A (ko) 세트랄린을 사용한 조기사정의 치료방법
ATE238792T1 (de) Verwendung von makroliden zur behandlung von glaukom
DE69426320D1 (de) Verwendung von silikon/fluorsilikon kopolymeröl zur herstellung eines arzneimittels zur behandlung von augenerkrankungen
KR950005310A (ko) 근시치료제의 제조방법
DE69028877T2 (de) Verwendung von Phenylethanolaminen zur Herstellung von Medikamenten gegen Augenleiden
ATE23112T1 (de) Verwendung von 1-(p-isopropoxyethoxymethylphenoxy)-3-isopropylamino-propan-2-ol zur herstellung eines arzneimittels zur senkung des augeninnendrucks.
KR890003373A (ko) 수면장애 및 우울증 치료에 화합물의 이용
ATE284209T1 (de) Verwendung einer pharmazeutischen zusammensetzung zur herstellung eines medikamentes zur behandlung von durch bakterien, viren, pilze, hefen und/oder protozoen verursachten augenerkrankungen
Rimmer et al. Effects of norepinephrine on blood glucose and free fatty acids in cold-adapted rats
ES2082212T3 (es) Nuevos inhibidores de alfa-glucosidasa.
CN1478493A (zh) 烫伤一抹清
KR960033465A (ko) 뽕나무를 이용한 치료제의 제조 방법
RU94044743A (ru) Глазная мазь
Pilcher et al. The treatment of wounds by flavine
Buller A rare form of ophthalmia granulosa associated with icthyosis
RU95113855A (ru) Способ консервативного лечения ожогов глаз
RU2139074C1 (ru) Способ получения бальзамического средства "капсопросан"
KR850001667A (ko) 불소화 피롤리돈 유도체의 제법 및 그 조성물
Burgoyne et al. Deformation of the Normal Monkey Optic Nerve Head (ONH) Connective Tissues Following Acute IOP Elevation Within 3D Histomorphometric Reconstructions
KR950018434A (ko) 삼백초를 주재로한 양조식초의 제조방법
DE2532693A1 (de) Verfahren zur herstellung eines oeles gegen hautekzeme

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee